Evidence map›Paper›PMID 32844107›Full record

ArticleEthics, medicine, and public health

COVID-19 response in Nigeria: Health system preparedness and lessons for future epidemics in Africa.

C C Etteh, M P Adoga, C C Ogbaga

Abstract read
In one paragraph

Article in Ethics, medicine, and public health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Views of Nigerian civil servants about compulsory COVID-19 vaccination: A qualitative study.African journal of primary health care & family medicine · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. COVID-19 in Africa: New opportunities created.Ethics, medicine, and public health · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C C EttehDepartment of medical biochemistry, Imo State university, Owerri, Imo State, Nigeria.
M P AdogaDepartment of microbiology, faculty of natural and applied sciences, Nasarawa State university, Keffi, Nigeria.
C C OgbagaDepartment of biological sciences, Nile university of Nigeria, Airport road, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) will continue to have a significant impact on the way we live for at least the next few years until the scale-up of production and administration of an effective vaccine. Unfortunately, this will not be the last pandemic of infectious diseases the world will experience, and the next one may have more devastating consequences in Africa than COVID-19, unless critical lessons for the future are learnt now for more rapid and robust containment measures. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral cause of COVID-19, is thought to have been introduced into the continent by returning travellers from hotspots in Asia, Europe and America. In a pandemic with Africa having relatively lower morbidity and mortality, it is alarming that in about five months since confirmation of the continent's first case of COVID-19 in Egypt on February 14th, 2020, the infection rate remains at an exponential phase with forty-seven African countries reporting a total of 766,803 cases, 13,191 deaths and 486,925 recoveries as at 31st July, 2020; out of which Nigeria reported 42,689 cases, 878 deaths and 19,290 recoveries, with Lagos State accounting for close to half of all cases in Nigeria. Importantly, lessons learnt during the Ebola epidemic have had a significant impact on Nigeria's COVID-19 response. In this article, we discuss Nigeria's response, health system preparedness and the lessons that are critical for containment of future outbreaks, epidemics or pandemics of any infectious disease in Africa.

Indexed as

AfricaCoronavirus disease 2019 (COVID-19)Health system preparednessNigeriaSARS-CoV-2

Identifiers

PMID32844107
PMCPMC7440033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.